These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 9519889)
1. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889 [TBL] [Abstract][Full Text] [Related]
2. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Traber KE; Okamoto H; Kurono C; Baba M; Saliou C; Soji T; Packer L; Okamoto T Int Immunol; 1999 Feb; 11(2):143-50. PubMed ID: 10069412 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin. Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor. Victoriano AF; Asamitsu K; Hibi Y; Imai K; Barzaga NG; Okamoto T Antimicrob Agents Chemother; 2006 Feb; 50(2):547-55. PubMed ID: 16436709 [TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. Okamoto M; Ono M; Baba M AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907 [TBL] [Abstract][Full Text] [Related]
6. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. Yang X; Chen Y; Gabuzda D J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3. Okada H; Takei R; Tashiro M FEBS Lett; 1998 Feb; 422(3):363-7. PubMed ID: 9498817 [TBL] [Abstract][Full Text] [Related]
8. Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil. Akari H; Yamamoto Y; Hiwada H; Saito Y; Takayanagi N; Koyama AH; Adachi A J Med Invest; 1998 Feb; 44(3-4):211-4. PubMed ID: 9597811 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK). Amici C; Belardo G; Rozera C; Bernasconi D; Santoro MG AIDS; 2004 Jun; 18(9):1271-80. PubMed ID: 15362659 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008 [TBL] [Abstract][Full Text] [Related]
13. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha. Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706 [TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351 [TBL] [Abstract][Full Text] [Related]
16. Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency. Critchfield JW; Ho O; Roberts BD; Van Lint C; Verdin E; Butera ST Antivir Chem Chemother; 1999 Sep; 10(5):275-84. PubMed ID: 10574182 [TBL] [Abstract][Full Text] [Related]
17. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. Sappey C; Boelaert JR; Legrand-Poels S; Forceille C; Favier A; Piette J AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1049-61. PubMed ID: 8554902 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ. Miyake A; Ishida T; Yamagishi M; Hara T; Umezawa K; Watanabe T; Horie R Microbes Infect; 2010 May; 12(5):400-8. PubMed ID: 20172044 [TBL] [Abstract][Full Text] [Related]
19. de Jesus MSM; Macabeo APG; Ramos JDA; de Leon VNO; Asamitsu K; Okamoto T Molecules; 2022 Feb; 27(3):. PubMed ID: 35164343 [TBL] [Abstract][Full Text] [Related]
20. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]